Ad is loading...
MENU
BEAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Beam Therapeutics (BEAM) Earnings Date & Reports

A.I. Advisor
published Earnings

BEAM is expected to report earnings to rise 6.84% to -125 cents per share on March 04

Beam Therapeutics BEAM Stock Earnings Reports
Q4'24
Est.
$-1.25
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.20
Q4'23
Beat
by $2.42
The last earnings report on November 05 showed earnings per share of -116 cents, beating the estimate of -117 cents. With 462.87K shares outstanding, the current market capitalization sits at 2.07B.
View a ticker or compare two or three
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com